A poorly structured legal foundation is often the primary reason for deal delays during a Series A round. Before writing the first line of commercial code or beginning lab trials, a company needs its legal “DNA”: the Certificate of Incorporation (the Charter) and the Corporate Bylaws.
While the Charter is a public document that officially creates the entity with the state, the Bylaws act as the internal “rulebook” for management. Together, they dictate ownership, decision-making authority, and eventual exit strategies.
For Delaware C-Corps, the undisputed gold standard for venture-backed startups, these documents are far more than administrative paperwork.
Funding rounds are frequently stalled or valuations negatively impacted because of simple errors, such as using a generic online template that fails to properly assign intellectual property or leaves “dead equity” (shares held by inactive participants or departed founders) on the cap table.
In tech and life sciences, where value is inextricably tied to IP, a “clean” legal start is the difference between a smooth closing and a failed due diligence process.
In the high-stakes world of biotech and software, “off-the-shelf” forms are a significant liability. Startups in these fields face unique pressures from intense regulatory scrutiny to the complex demands of venture capital partners who expect absolute legal clarity.
As your Startup Governance Lawyer, Crowley Law ensures that internal structures can withstand the weight of rapid expansion and multi-million dollar investments. This is the same level of governance investors expect from companies exiting at $100M+.
Custom-tailored governance documents provide several critical layers of protection:
While an LLC might seem easier for taxes, it is rarely suitable for companies seeking institutional investment. Investors and founders in the tech and life sciences spaces prefer the Delaware C-Corp for its predictable legal framework and its ability to handle complex equity structures.
Feature | Delaware C-Corp | LLC (Limited Liability Company) |
Investor Preference | Preferred by 99% of VCs/Institutional Investors. | Generally avoided by VCs due to tax complexity (K-1s). |
Equity Flexibility | Easy to issue stock options and preferred shares. | Complex to issue equity-like incentives (Profits Interests). |
Exit Strategy | Designed for IPOs and smooth acquisitions. | Conversion to a C-Corp often involves significant tax and legal friction. |
Governance | Formalized structure (Board, Officers, Bylaws). | Flexible, but often leads to ambiguity in scaling phases. |
The Certificate of Incorporation is the public face of the company. It must be drafted with a long-term view, anticipating the requirements of three rounds of funding, not just current needs. As your Life Sciences Corporate Counsel, Crowley Law embeds flexibility directly into the core filing to minimize the need for complex retroactive amendments.
Key components include:
If the Charter is the skeleton, the Bylaws are the nervous system. They dictate how the company breathes on a day-to-day basis. Without robust Bylaws, a startup risks operational paralysis or internal power struggles that can hinder development timelines.
Crowley Law’s Bylaws Attorney services focus on:
Incorporation is frequently viewed as a “checkbox” item. This leads to “legal debt,” poorly drafted documents that must be rewritten at significantly higher costs during a funding round.
Real-World Pitfalls to Avoid:
We do not just provide documents; the firm serves as a strategic partner, understanding the high-growth trajectory of tech and life sciences. The practice combines “big firm” sophistication with a personalized, hands-on approach.
Crowley Law LLC combines decades of corporate legal experience with personalized counsel tailored to the unique needs of startups. The firm is led by Philip P. Crowley, with over 45 years of experience, including prior service as corporate counsel at Johnson & Johnson, where he managed complex confidentiality and licensing matters.
Crowley Law focuses on providing strategic, practical advice that helps founders and investors build strong structures, secure funding, and navigate growth smoothly. Their hands-on approach ensures legal solutions that protect value and support long-term success.
Before your next funding round, ensure your governance is ironclad.
Predictability. The Delaware Court of Chancery specializes in corporate law, meaning judges (not juries) resolve disputes based on deep knowledge. Investors trust it because the legal “rules of the game” are stable and well-understood.
Bylaws aren’t “set and forget.” They should be reviewed before every major funding round (Series A, B, etc.), when restructuring your Board of Directors, or if the company pivots into a significantly different regulatory landscape.
Missing IP assignment agreements and “messy” cap tables. If shares were promised to an early advisor without signed paperwork, it will delay the deal. Crowley Law identifies and fixes these issues before investors see them.
While possible, it is often a complex tax and legal process. Conversion involves expensive filings and potentially difficult equity swaps. To raise venture capital, it is best to start as a Delaware C-Corp to avoid unnecessary future costs.
Lack of drag-along rights. Without them, a single disgruntled minority shareholder could potentially block the sale of the company, even if the founders and 99% of shareholders desire the exit.
